Author:
Bourhis Amélie,Trabelsi Nesrine,Karachi Carine,Idbaih Ahmed,Bielle Franck
Funder
Université Pierre et Marie Curie
Institut National Du Cancer
Subject
Pathology and Forensic Medicine
Reference5 articles.
1. WHO classification of tumours of the central nervous system. Revised 4th edition;Weltgesundheitsorganisation,2016
2. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma;Mistry;J Clin Oncol,2015
3. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases | Modern Pathology [Internet]. [cité 1 juill 2020]. Disponible sur: https://www.nature.com/articles/modpathol201562.
4. Simultaneous endocrine expression and loss of melanoma markers in malignant melanoma metastases, a retrospective analysis;Steppert;Pathol Oncol Res.,2020
5. Pigmented ganglioglioma of the cerebellum: case report and review;Agrawal;World Neurosurg,2018